Global Plasma Derived Therapies Market To Record Protruding Growth With US$ 39,961.8 Million By 2028

July 2022 | Report Format: Electronic (PDF)

The plasma portion of blood is a transparent yellow or light brown fluid component of the blood. Plasma-derived medications (PDMPs) are manufactured from plasma samples and include clotting factors, immunoglobulins, and albumin all of which are life-saving therapeutic target for a range of acute and chronic life-threatening diseases such as hereditary immunodeficiency diseases, hereditary coagulation disorders, and others.

The rising frequency of autoimmune illnesses, autoimmune disease disorders, neurologic and blood disorders are the primary drivers driving market growth. Along with these considerations, the global increase in the aging populations is a key driver of market expansion, since the old are more vulnerable to neurological illnesses.

Furthermore, increasing expenditures in R&D initiatives by pharmaceutical and biotechnology businesses are driving market expansion. The ongoing R&D in the plasma segment is expected to boost its use in a variety of applications. The increased use of therapeutic protein medicines in the treatment of a wide variety of clinical complaints is expected to provide this market with unique growth prospects in the future years.

Request a Free Sample Copy: Plasma Derived Therapies Market Report

Plasma Derived Therapies Market Report Highlights

• In November 2021, Grifols, S.A., a leading global producer of plasma-derived medicines, announced the launch of albumin ALBUTEIN FlexBag (Albumin [Human] U.S.P.) in 5% and 25% concentrations. ALBUTEIN is derived from plasma and is indicated for cardiopulmonary bypass procedures, hypovolemia, hypoalbuminemia, and plasma exchange.
• in January 2022, ADMA Biologics, Inc., an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty plasma-derived biologics, announced that it had received U.S. Food and Drug Administration (FDA) approval for its fourth ADMA BioCenters plasma collection facility located in Goose Creek, South Carolina.

PLASMA DERIVED THERAPIES MARKET SEGMENTATION

The research report published by Market Research Strategy contains industry segments, as below-

Plasma Derived Therapies Product Outlook (Revenue, USD Million, 2017 - 2028)

• Albumin
• Immunoglobulin
• Factor VIII
• Others

Plasma Derived Therapies Application Outlook (Revenue, USD Million, 2017 - 2028)

• Hemophilia
• Idiopathic Thrombocytopenic Purpura
• Primary Immunodeficiencies
• Other Applications

Plasma Derived Therapies Regional Outlook (Revenue, USD Million, 2017 - 2028)

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • U.K.
  • France
  • Italy
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
• Central & South America
  • Brazil
  • Argentina
• Middle East & Africa
  • Saudi Arabia
  • South Africa

List of Key Players- Plasma Derived Therapies Market

• Takeda
• SK Plasma
• Shire
• Octaparma
• LFB
• Kedrion
• Grifols
• Fusion Healthcare
• CSL Behring LLC
• China Biologic Products Holdings Inc.
• Biotest
• Bio Products Laboratory (BPL)
• Bayer
• Baxter
• ADMA Biologics Inc.

About Market Research Strategy:

Market Research Strategy (MRS) is a dedicated and disciplined market research firm that delivers authentic consulting services with accurate data forecasting for research-related services. The positive and result-oriented approaches implemented by us are beneficial in identifying the market challenges of any brand or start-up company to penetrate the competitive business space.

MRS also supports numerous organizations with its syndicate data and research reports to establish and survive in the market by grabbing the available market opportunities. Our vast experience and huge client database turn out to be our wealth and also secures our market position at the top of the list. Besides, we make use of every single piece of information, mined from authentic sources, into a valuable asset of the report; aiding our clients with informed business decisions.

Contact Us:

Market Research Strategy

473 Mundet Place,

Ste US520501 Hillside

New Jersey 07205 United States

USA Phone: +1 9176726599

Business Email: sales@marketresearchstrategy.com

Website: https://marketresearchstrategy.com/